Verona Pharma (VRNA) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free VRNA Stock Alerts $15.47 +0.16 (+1.05%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJennison Associates LLC Acquires 142,819 Shares of Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - April 25 at 7:26 AMVerona Pharma shares target raised on COPD launch outlookinvesting.com - April 25 at 3:40 AMVerona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Updateglobenewswire.com - April 25 at 2:00 AMVerona Pharma (NASDAQ:VRNA) Price Target Increased to $36.00 by Analysts at Piper Sandleramericanbankingnews.com - April 17 at 3:36 AMVerona Pharma (NASDAQ:VRNA) Trading 3.7% Higher After Analyst Upgradeamericanbankingnews.com - April 17 at 1:08 AMVerona Pharma (NASDAQ:VRNA) Stock Price Up 3.7% on Analyst Upgrademarketbeat.com - April 16 at 10:36 AMVerona Pharma (NASDAQ:VRNA) PT Raised to $36.00 at Piper Sandlermarketbeat.com - April 16 at 8:33 AMVerona Pharma (NASDAQ:VRNA) Shares Up 4.9%marketbeat.com - April 4 at 3:08 PMAmerican Century Companies Inc. Purchases Shares of 280,126 Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - March 28 at 4:07 AMWellington Management Group LLP Acquires 164,268 Shares of Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - March 19 at 4:54 AMVRNA Apr 2024 17.500 callfinance.yahoo.com - March 16 at 8:32 AMVRNA Apr 2024 15.000 callfinance.yahoo.com - March 16 at 3:31 AMVerona Pharma (NASDAQ:VRNA) Trading Down 7.6%marketbeat.com - March 14 at 12:47 PMAdage Capital Partners GP L.L.C. Buys 208,100 Shares of Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - March 10 at 6:37 AMResearch Analysts Set Expectations for Verona Pharma plc's Q3 2024 Earnings (NASDAQ:VRNA)marketbeat.com - March 7 at 7:22 AMVerona Pharma plc (NASDAQ:VRNA) Forecasted to Post Q4 2025 Earnings of ($0.01) Per Sharemarketbeat.com - March 6 at 8:32 AMVerona Pharma (NASDAQ:VRNA) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - March 4 at 8:25 AMAndrew Fisher Joins Verona Pharma as General Counselglobenewswire.com - March 4 at 2:00 AMBuy Rating Affirmed: Verona Pharma’s Promising Future with Ensifentrine and Expanding R&D Pipelinemarkets.businessinsider.com - March 1 at 1:10 PMVerona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 1 at 1:10 PMVerona Pharma (NASDAQ:VRNA) Rating Reiterated by Wedbushmarketbeat.com - March 1 at 9:16 AM3 Healthcare Stocks That Have Outperformed Nvidia Since 2022fool.com - March 1 at 8:45 AMVerona Pharma plc 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 29 at 11:18 AMVerona Pharma plc: Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - February 29 at 10:48 AMVerona Pharma PLC Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 29 at 10:48 AMVerona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - February 29 at 2:00 AMVerona Pharma earnings preview: what to expectmarkets.businessinsider.com - February 28 at 1:35 PMAvidity Partners Management LP Sells 124,200 Shares of Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - February 27 at 4:26 PMWhen Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?finance.yahoo.com - February 25 at 12:52 PMVerona Pharma PLC ADRwsj.com - February 25 at 7:52 AMFederated Hermes Inc. Has $40.65 Million Stock Position in Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - February 23 at 8:38 AMVRNA Mar 2024 15.000 putfinance.yahoo.com - February 17 at 7:46 PMVRNA Jun 2024 30.000 callfinance.yahoo.com - February 17 at 2:46 PMVerona Pharma: A Few Points From The Bull And Bear Caseseekingalpha.com - February 15 at 5:55 PMVerona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Updatefinance.yahoo.com - February 15 at 10:20 AMVerona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Updateglobenewswire.com - February 15 at 2:00 AMVerona Pharma (NASDAQ:VRNA) Trading 2% Higher marketbeat.com - February 13 at 1:32 PMCampbell & CO Investment Adviser LLC Takes Position in Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - February 11 at 7:17 AMVerona Pharma (NASDAQ:VRNA) Trading Down 5.3%marketbeat.com - February 2 at 1:37 PMVerona Pharma PLC ADR (VRNA)investing.com - January 23 at 6:17 PMVerona Pharma's (VRNA) Buy Rating Reiterated at HC Wainwrightmarketbeat.com - January 22 at 8:23 AMVerona Pharma: Upcoming PDUFA, Expired Patent, Strong Dataseekingalpha.com - January 19 at 5:30 PMVerona Pharma plc's (NASDAQ:VRNA) latest 11% decline adds to one-year losses, institutional investors may consider drastic measuresfinance.yahoo.com - January 15 at 12:56 PMPiper Sandler Reaffirms Their Buy Rating on Verona Pharma (VRNA)markets.businessinsider.com - January 11 at 6:01 PMVerona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 3 at 8:49 AMVerona Pharma plc: Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capitalfinanznachrichten.de - January 2 at 7:52 AMVerona Pharma Secures Debt Facility Of Up To $400 Mlnmarkets.businessinsider.com - January 2 at 7:52 AMVerona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capitalfinance.yahoo.com - January 2 at 7:52 AMBuy Rating for Verona Pharma Amid Potential GSK Acquisition and Anticipated FDA Approvalmarkets.businessinsider.com - December 30 at 10:13 AMVerona Pharma (NASDAQ:VRNA) Given "Buy" Rating at HC Wainwrightmarketbeat.com - December 29 at 8:45 AM Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. VRNA Media Mentions By Week VRNA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRNA News Sentiment▼0.780.32▲Average Medical News Sentiment VRNA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRNA Articles This Week▼32▲VRNA Articles Average Week Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DAWN News GYRE News PCRX News ANIP News IRWD News KNSA News MORF News LGND News KURA News DCPH News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRNA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
